189 related articles for article (PubMed ID: 12055224)
21. Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity.
Ozawa H; Ding W; Torii H; Hosoi J; Seiffert K; Campton K; Hackett NR; Topf N; Crystal RG; Granstein RD
J Invest Dermatol; 1999 Dec; 113(6):999-1005. PubMed ID: 10594743
[TBL] [Abstract][Full Text] [Related]
22. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
Atarashi K; Kabashima K; Akiyama K; Tokura Y
Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
[TBL] [Abstract][Full Text] [Related]
23. Regulation of tumor antigen presentation by urocanic acid.
Beissert S; Mohammad T; Torri H; Lonati A; Yan Z; Morrison H; Granstein RD
J Immunol; 1997 Jul; 159(1):92-6. PubMed ID: 9200443
[TBL] [Abstract][Full Text] [Related]
24. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects.
Asahina A; Moro O; Hosoi J; Lerner EA; Xu S; Takashima A; Granstein RD
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8323-7. PubMed ID: 7667288
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin gene-related peptide and Langerhans cell function.
Torii H; Hosoi J; Asahina A; Granstein RD
J Investig Dermatol Symp Proc; 1997 Aug; 2(1):82-6. PubMed ID: 9487021
[TBL] [Abstract][Full Text] [Related]
26. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity.
Wang B; Feliciani C; Howell BG; Freed I; Cai Q; Watanabe H; Sauder DN
J Immunol; 2002 Apr; 168(7):3303-8. PubMed ID: 11907086
[TBL] [Abstract][Full Text] [Related]
27. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75.
Wang B; Fujisawa H; Zhuang L; Kondo S; Shivji GM; Kim CS; Mak TW; Sauder DN
J Immunol; 1997 Dec; 159(12):6148-55. PubMed ID: 9550416
[TBL] [Abstract][Full Text] [Related]
28. Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity.
Girolomoni G; Pastore S; Zacchi V; Cavani A; Marconi A; Giannetti A
J Immunol; 1993 May; 150(10):4236-43. PubMed ID: 8482834
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Beissert S; Granstein RD
J Leukoc Biol; 1994 Jun; 55(6):695-701. PubMed ID: 8195694
[TBL] [Abstract][Full Text] [Related]
30. Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity.
Kurimoto I; Grammer SF; Shimizu T; Nakamura T; Streilein JW
Immunology; 1995 Aug; 85(4):621-9. PubMed ID: 7558158
[TBL] [Abstract][Full Text] [Related]
31. Antigen presentation by epidermal Langerhans cells in experimental cutaneous leishmaniasis.
Axelrod O; Klaus S; Frankenburg S
Parasite Immunol; 1994 Nov; 16(11):593-8. PubMed ID: 7862465
[TBL] [Abstract][Full Text] [Related]
32. CCCTC-binding factor controls the homeostatic maintenance and migration of Langerhans cells.
Kim TG; Kim M; Lee JJ; Kim SH; Je JH; Lee Y; Song MJ; Choi Y; Chung YW; Park CG; Cho JW; Lee MG; Lee YS; Kim HP
J Allergy Clin Immunol; 2015 Sep; 136(3):713-24. PubMed ID: 25936568
[TBL] [Abstract][Full Text] [Related]
33. The effect of neuropeptides/hormones on Langerhans cells.
Torii H; Tamaki K; Granstein RD
J Dermatol Sci; 1998 May; 20(1):21-8. PubMed ID: 10342745
[TBL] [Abstract][Full Text] [Related]
34. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
35. Roxithromycin down-modulates antigen-presenting and interleukin-1 beta-producing abilities of murine Langerhans cells.
Ohshima A; Tokura Y; Wakita H; Furukawa F; Takigawa M
J Dermatol Sci; 1998 Jul; 17(3):214-22. PubMed ID: 9697050
[TBL] [Abstract][Full Text] [Related]
36. Modulation of skin norepinephrine turnover by allergen sensitization: impact on contact hypersensitivity and T helper priming.
Maestroni GJ
J Invest Dermatol; 2004 Jan; 122(1):119-24. PubMed ID: 14962099
[TBL] [Abstract][Full Text] [Related]
37. Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells.
Sullivan S; Bergstresser PR; Tigelaar RE; Streilein JW
J Immunol; 1986 Oct; 137(8):2460-7. PubMed ID: 2876041
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis.
Halliday GM; Lucas AD
Immunology; 1993 Aug; 79(4):621-6. PubMed ID: 8406587
[TBL] [Abstract][Full Text] [Related]
39. Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells.
Katayama I; Matsunaga T; Yokozeki H; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):846-52. PubMed ID: 9217815
[TBL] [Abstract][Full Text] [Related]
40. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin.
Enk AH; Angeloni VL; Udey MC; Katz SI
J Immunol; 1993 May; 150(9):3698-704. PubMed ID: 8473727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]